相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Chemical Biology Approach to Developing STAT Inhibitors: Molecular Strategies for Accelerating Clinical Translation
Erik A. Nelson et al.
Oncotarget (2015)
The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse
Obul R. Bandapalli et al.
HAEMATOLOGICA (2014)
Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2
Suhu Liu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells
Warren Fiskus et al.
MOLECULAR CANCER THERAPEUTICS (2014)
BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD
Warren Fiskus et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia
M. Kontro et al.
LEUKEMIA (2014)
The Synthetic α-Bromo-2′,3,4,4′-Tetramethoxychalcone (α-Br-TMC) Inhibits the JAK/STAT Signaling Pathway
Sophia Pinz et al.
PLOS ONE (2014)
The Natural Chemopreventive Agent Sulforaphane Inhibits STAT5 Activity
Sophia Pinz et al.
PLOS ONE (2014)
JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia
Wolfgang Warsch et al.
BLOOD (2013)
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
Hanna L. M. Rajala et al.
BLOOD (2013)
Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
Alfonso Quintas-Cardama et al.
CLINICAL CANCER RESEARCH (2013)
JAK1/2 and Pan-Deacetylase Inhibitor Combination Therapy Yields Improved Efficacy in Preclinical Mouse Models of JAK2V617F-Driven Disease
Emeline Evrot et al.
CLINICAL CANCER RESEARCH (2013)
Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition
Reecha D. Shah et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing
Jarmila Hnilicova et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
The Inhibition of Stat5 by a Peptide Aptamer Ligand Specific for the DNA Binding Domain Prevents Target Gene Transactivation and the Growth of Breast and Prostate Tumor Cells
Axel Weber et al.
PHARMACEUTICALS (2013)
Acetylation modulates the STAT signaling code
Martin Wieczorek et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
The HAT/HDAC interplay: Multilevel control of STAT signaling
Laura Icardi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Berkley E. Gryder et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Critical Role of STAT5 Transcription Factor Tetramerization for Cytokine Responses and Normal Immune Function
Jian-Xin Lin et al.
IMMUNITY (2012)
Bromodomain Protein Brd4 Associated with Acetylated Chromatin Is Important for Maintenance of Higher-order Chromatin Structure
Ranran Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Breakdown of the FLT3-ITD/STAT5 Axis and Synergistic Apoptosis Induction by the Histone Deacetylase Inhibitor Panobinostat and FLT3-Specific Inhibitors
Kristin Pietschmann et al.
MOLECULAR CANCER THERAPEUTICS (2012)
SUMO-Specific Protease 1 Is Critical for Early Lymphoid Development through Regulation of STAT5 Activation
Thang Van Nguyen et al.
MOLECULAR CELL (2012)
BET domain co-regulators in obesity, inflammation and cancer
Anna C. Belkina et al.
NATURE REVIEWS CANCER (2012)
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
Erik A. Nelson et al.
BLOOD (2011)
HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo
Tri Nguyen et al.
CLINICAL CANCER RESEARCH (2011)
The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
Shaila Rahman et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Division of labor by dual feedback regulators controls JAK2/STAT5 signaling over broad ligand range
Julie Bachmann et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2
Malay Mandal et al.
NATURE IMMUNOLOGY (2011)
STAT5 Activation Is Critical for the Transformation Mediated by Myeloproliferative Disorder-associated JAK2 V617F Mutant
Megumi Funakoshi-Tago et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
p300-mediated Acetylation of Histone H3 Lysine 56 Functions in DNA Damage Response in Mammals
Rahul K. Vempati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phosphorylation-acetylation switch in the regulation of STAT1 signaling
Oliver H. Kraemer et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Acetylation modulates prolactin receptor dimerization
Li Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells
Yongchao Wang et al.
BLOOD (2009)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes
Anne Rascle et al.
EXPERIMENTAL CELL RESEARCH (2009)
A phosphorylation-acetylation switch regulates STAT1 signaling
Oliver H. Kraemer et al.
GENES & DEVELOPMENT (2009)
STAT3 inhibition of gluconeogenesis is downregulated by SirT1
Yongzhan Nie et al.
NATURE CELL BIOLOGY (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
HDAC2: a critical factor in health and disease
Oliver H. Kraemer
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Histone acetyltransferase-1 regulates integrity of cytosolic histone H3-H4 containing complex
Hirak Kumar Barman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Discovery of chromone-based inhibitors of the transcription factor STAT5
Judith Mueller et al.
CHEMBIOCHEM (2008)
The STAT3 NH2-terminal Domain Stabilizes Enhanceosome Assembly by Interacting with the p300 Bromodomain
Tieying Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
Marielle Fournel et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription
Gary LeRoy et al.
MOLECULAR CELL (2008)
In vivo identification of novel STAT5 target genes
Beth Basham et al.
NUCLEIC ACIDS RESEARCH (2008)
Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution
Sutapa Ray et al.
NUCLEIC ACIDS RESEARCH (2008)
Acetylation mimics within individual core histone tail domains indicate distinct roles in regulating the stability of higher-order chromatin structure
Xiaodong Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Acetylation-dependent signal transduction for type I interferon receptor
Xiaoli Tang et al.
CELL (2007)
Disruption of HDAC4N-CoR complex by histone deacetylase inhibitors leads to inhibition of IL-2 gene expression
Hideaki Matsuoka et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation
Jinhong Peng et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
JAW/STAT signal transduction: Regulators and implication in hematological malignancies
L Valentino et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines
GV Denis et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Acetylation of Stat1 modulates NF-κB activity
OH Krämer et al.
GENES & DEVELOPMENT (2006)
Histone H4-K16 acetylation controls chromatin structure and protein interactions
M Shogren-Knaak et al.
SCIENCE (2006)
STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen
S Ray et al.
GASTROENTEROLOGY (2005)
A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response
H Masumoto et al.
NATURE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation
R Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Specific contributions of histone tails and their acetylation to the mechanical stability of nucleosomes
B Brower-Toland et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Stat3 dimerization regulated by reversible acetylation of a single lysine residue
ZL Yuan et al.
SCIENCE (2005)
Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs
C Luo et al.
DRUG DISCOVERY TODAY (2004)
Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases
MH Brush et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Requirement of histone deacetylase activity for signaling by STAT1
L Klampfer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter
R Métivier et al.
CELL (2003)
NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the α-helical region of the STAT5 transactivation domain
CM Litterst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5
A Rascle et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Identification of novel isoform-selective inhibitors within class I histone deacetylases
ED Hu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription
A Rascle et al.
NUCLEIC ACIDS RESEARCH (2003)
Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation
T Nosaka et al.
EXPERIMENTAL HEMATOLOGY (2002)
Loss of Stat5a delays mammary cancer progression in a mouse model
SX Ren et al.
ONCOGENE (2002)
Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription
H Nakajima et al.
EMBO JOURNAL (2001)
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation
VM Richon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Modulation of STAT signaling by STAT-interacting proteins
K Shuai
ONCOGENE (2000)
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
J Schwaller et al.
MOLECULAR CELL (2000)
分享论文
